BSE
VIMTALABS

VIMTA LABS LTD.-$

Diagnostics & Research
Healthcare

Prices are adjusted according to historical splits.

VIMTA LABS LTD.-$ Stock Price

Vitals

Today's Low:
₹548.25
Today's High:
₹580.95
Open Price:
₹572
52W Low:
₹291
52W High:
₹503.8
Prev. Close:
₹566.05
Volume:
6992

Company Statistics

Market Cap.:
₹7.36 billion
Book Value:
116.267
Revenue TTM:
₹3.11 billion
Operating Margin TTM:
20.94%
Gross Profit TTM:
₹2.00 billion
Profit Margin:
15.22%
Return on Assets TTM:
13.27%
Return on Equity TTM:
20.96%

Company Profile

VIMTA LABS LTD.-$ had its IPO on under the ticker symbol VIMTALABS.

The company operates in the Healthcare sector and Diagnostics & Research industry. VIMTA LABS LTD.-$ has a staff strength of 1,286 employees.

Stock update

Shares of VIMTA LABS LTD.-$ opened at ₹572 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹548.25 - ₹580.95, and closed at ₹554.4.

This is a -2.06% slip from the previous day's closing price.

A total volume of 6,992 shares were traded at the close of the day’s session.

In the last one week, shares of VIMTA LABS LTD.-$ have slipped by -4.53%.

VIMTA LABS LTD.-$'s Key Ratios

VIMTA LABS LTD.-$ has a market cap of ₹7.36 billion, indicating a price to book ratio of 3.6526 and a price to sales ratio of 3.1121.

In the last 12-months VIMTA LABS LTD.-$’s revenue was ₹3.11 billion with a gross profit of ₹2.00 billion and an EBITDA of ₹886.25 million. The EBITDA ratio measures VIMTA LABS LTD.-$'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, VIMTA LABS LTD.-$’s operating margin was 20.94% while its return on assets stood at 13.27% with a return of equity of 20.96%.

In Q4, VIMTA LABS LTD.-$’s quarterly earnings growth was a negative -12.8% while revenue growth was a positive 14.9%.

VIMTA LABS LTD.-$’s PE and PEG Ratio

Forward PE
0
Trailing PE
15.2832
PEG

Its diluted EPS in the last 12-months stands at ₹21.72 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into VIMTA LABS LTD.-$’s profitability.

VIMTA LABS LTD.-$ stock is trading at a EV to sales ratio of 3.1141 and a EV to EBITDA ratio of 9.7649. Its price to sales ratio in the trailing 12-months stood at 3.1121.

VIMTA LABS LTD.-$ stock pays annual dividends of ₹0 per share, indicating a yield of 0.66% and a payout ratio of 9.53%.

Balance sheet and cash flow metrics

Total Assets
₹0
Total Liabilities
₹0
Operating Cash Flow
₹0
Capital Expenditure
₹0
Dividend Payout Ratio
9.53%

VIMTA LABS LTD.-$ ended 2024 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.

VIMTA LABS LTD.-$ ended 2024 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

VIMTA LABS LTD.-$’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.

In 2024, VIMTA LABS LTD.-$'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, VIMTA LABS LTD.-$ paid ₹0.10 in dividends in 2024.

Other key metrics

Current Trading Price
₹554.4
52-Week High
₹503.8
52-Week Low
₹291
Analyst Target Price

VIMTA LABS LTD.-$ stock is currently trading at ₹554.4 per share. It touched a 52-week high of ₹503.8 and a 52-week low of ₹503.8. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹500.83 and 200-day moving average was ₹410.35 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6741.1% of the company’s stock are held by insiders while 190.6% are held by institutions.

Frequently Asked Questions About VIMTA LABS LTD.-$

The stock symbol (also called stock or share ticker) of VIMTA LABS LTD.-$ is VIMTALABS

The IPO of VIMTA LABS LTD.-$ took place on

Similar Industry Stocks (Diagnostics & Research)

Last Price
Chg
Chg%
₹682.05
-28.1
-3.96%
₹41.71
-1.36
-3.16%
Croissance Ltd (CROISSANCE)
₹4.65
-0.09
-1.9%
₹44.42
-0.71
-1.57%
₹4.7
-0.04
-0.84%
₹759.5
-47.6
-5.9%
ICICI Bank Limited (ICICIBANK)
₹990.9
12.55
+1.28%
₹28.61
-0.58
-1.99%
₹6.08
0.09
+1.5%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

Vimta Labs Limited provides contract research and testing services in India and internationally. It offers laboratory, food and water testing and analysis, preclinical and clinical research, biological molecule structural and functional analysis, environmental assessment, and clinical reference laboratory services. The company serves pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and various other industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Address

Plot Nos. 141/2 & 142, IDA, Phase II, Hyderabad, India, 500051